Lars Zender
- Cancer Research top 0.2%
- Aging top 0.5%
- Hepatology top 0.5%
- Molecular Biology top 0.2%
- RNA Interference and Gene Delivery 17
- Ubiquitin and proteasome pathways 12
- RNA Research and Splicing 11
- Immunology top 0.5%
- interferon and immune responses 10
-
- Cancer-related Molecular Pathways 20
-
- Virus-based gene therapy research 18
-
- Cancer Research and Treatments 15
-
- Telomeres, Telomerase, and Senescence 15
- Co-authors
- Scott W. LoweWen XueCarlos Cordon‐CardoValery KrizhanovskyGregory J. HannonEva HernandoRoss A. DickinsCornelius Miething
- Cited by
- Cancer ResearchAgingHepatology
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Lars Zender
157 papers receiving 15.6k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Cancer Research 4.1k
- Aging 408
- Hepatology 1.2k
- Molecular Biology 10.0k
- Immunology 3.0k
Countries citing papers authored by Lars Zender
This map shows the geographic impact of Lars Zender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Zender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Zender more than expected).
Fields of papers citing papers by Lars Zender
This network shows the impact of papers produced by Lars Zender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Zender. The network helps show where Lars Zender may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lars Zender, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2023 | 16 | |
| 3 | 2023 | 10 | |
| 4 | 2023 | 18 | |
| 5 | 2023 | 0 | |
| 6 | 2021 | 19 | |
| 7 | 2020 | 22 | |
| 8 | 2019 | 31 | |
| 9 | Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice | 2017 | 1 |
| 10 | 2016 | 100 | |
| 11 | 2016 | 29 | |
| 12 | Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progressionbreakdown → | 2016 | 447 |
| 13 | 2016 | 366 | |
| 14 | 2015 | 12 | |
| 15 | 2013 | 162 | |
| 16 | 2010 | 147 | |
| 17 | 2009 | 81 | |
| 18 | 2008 | 93 | |
| 19 | 2006 | 19 | |
| 20 | 2003 | 3 |
About Lars Zender
Lars Zender is a scholar working on Cancer Research, Hepatology, Oncology, Biotechnology and Immunology, having authored 164 papers that have together received 15.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (20 papers), Virus-based gene therapy research (18 papers), RNA Interference and Gene Delivery (17 papers), Cancer Research and Treatments (15 papers), Telomeres, Telomerase, and Senescence (15 papers), Ubiquitin and proteasome pathways (12 papers), RNA Research and Splicing (11 papers) and interferon and immune responses (10 papers). The work is most often cited by research in Cancer Research (4.1k citations), Aging (408 citations), Hepatology (1.2k citations), Molecular Biology (10.0k citations) and Immunology (3.0k citations). Lars Zender has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Scott W. Lowe, Wen Xue, Carlos Cordon‐Cardo, Valery Krizhanovsky, Gregory J. Hannon, Eva Hernando, Ross A. Dickins, Cornelius Miething, Michael P. Manns and Stefan Kubicka. Their work appears in journals such as Journal of Hepatology, Cancer Research, Hepatology, Cell and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.